TIDES GROUP, LLC

Lobbying for SIGA TECHNOLOGIES, INC. · biodefense countermeasure pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $140,000.00 income · posted Apr 17, 2026

Lobbying activity 3

Budget/Appropriations

Issues related to biodefense countermeasures, strategic national stockpile, pandemic response.

Defense

Issues related to biodefense countermeasures, strategic national stockpile, pandemic response.

Health Issues

Issues related to biodefense countermeasures, strategic national stockpile, pandemic response.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.